Advancements in Nanotechnology for Targeted Drug Delivery in Idiopathic Pulmonary Fibrosis: A Focus on Solid Lipid Nanoparticles and Nanostructured Lipid Carriers

Objective This review aims to explore innovative therapeutic strategies, with a particular focus on recent advancements in drug delivery systems using bioinspired nanomaterials such as solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for the Idiopathic pulmonary fibrosis (IPF).